Company Number: 14943579

Analysis Date: 2025-07-19 12:14 UTC

Financial Health Assessment Report for LUNAR TECHNOLOGY LIMITED

---

1. Financial Health Score: B (Good)

Explanation:
LUNAR TECHNOLOGY LIMITED demonstrates a solid financial position for a young micro-entity. The company boasts strong net current assets and net assets relative to its size, indicating a "healthy cash flow" and "strong balance sheet" for its early stage. However, the absence of operating profit data and minimal liabilities suggest the company is still in its infancy with limited operational history, warranting a cautious but optimistic grade.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	100,983	Healthy pool of liquid assets indicating good liquidity.
Current Liabilities	73	Very low short-term obligations; minimal financial strain.
Net Current Assets (Working Capital)	100,910	Strong working capital, a good sign of short-term financial health.
Net Assets (Equity)	100,310	Positive net worth, indicating the company is solvent.
Number of Employees	Nil	No employee overheads, typical for a start-up phase.

Interpretation of Vital Signs:

• The "healthy cash flow" analogy fits well here as the company holds significant current assets (likely cash or receivables) with almost no short-term debts, enabling smooth day-to-day operations.
• The high net current assets suggest no immediate liquidity issues, which is a critical symptom of financial wellness.
• The absence of employees and limited liabilities indicates the company is likely in its setup or early development phase rather than active trading with operational complexity.

---

3. Diagnosis

LUNAR TECHNOLOGY LIMITED presents as a financially solvent and stable start-up with strong liquidity and equity base. The key "symptoms" are:

• Strong working capital: Indicates the company can meet short-term obligations comfortably.
• Positive net assets: No evidence of financial distress; shareholders’ funds exceed liabilities.
• No audit requirement: Micro-entity exemption aligns with small scale and low complexity.
• No employees: Suggests early stage with minimal operating expenses.

However, there are some considerations:

• The company’s financial statements do not show trading results or profitability metrics, so operational performance is not yet measurable.
• The company is very new (incorporated June 2023), so historical data for trend analysis is unavailable.
• Minimal liabilities and creditors could mean limited business activity to date.

In medical terms, the company is like a patient in early recovery with vital signs stable and no acute distress but lacking the test results (profit/loss) to fully assess long-term health.

---

4. Recommendations

To further strengthen financial wellness and improve prognosis:

1. Begin generating and monitoring operational metrics: Track revenue, gross margin, and expenses to diagnose profitability and operational efficiency.
2. Maintain strong liquidity management: Continue to preserve cash reserves and monitor working capital to avoid symptoms of cash flow stress as business expands.
3. Prepare for growth-related costs: Plan for employee hiring and increased liabilities which are typical as the company scales. Early budgeting and cash flow forecasting will be vital.
4. Ensure timely compliance: Continue punctual filing of accounts and confirmation statements to avoid penalties and maintain regulatory health.
5. Consider formal financial audit or review: As the company grows beyond micro thresholds, a more rigorous financial examination will provide stakeholders with greater confidence.

---